International Journal of Nanomedicine,
Год журнала:
2025,
Номер
Volume 20, С. 1443 - 1490
Опубликована: Фев. 1, 2025
Abstract:
Given
the
complexity
of
central
nervous
system
(CNS)
and
diversity
neurological
conditions,
increasing
prevalence
disorders
poses
a
significant
challenge
to
modern
medicine.
These
disorders,
ranging
from
neurodegenerative
diseases
psychiatric
not
only
impact
individuals
but
also
place
substantial
burden
on
healthcare
systems
society.
A
major
obstacle
in
treating
these
conditions
is
blood-brain
barrier
(BBB),
which
restricts
passage
therapeutic
agents
brain.
Nanotechnology,
particularly
use
nanoparticles
(NPs),
offers
promising
solution
this
challenge.
NPs
possess
unique
properties
such
as
small
size,
large
surface
area,
modifiable
characteristics,
enabling
them
cross
BBB
deliver
drugs
directly
affected
brain
regions.
This
review
focuses
application
gene
therapy
enzyme
replacement
(ERT)
for
disorders.
Gene
involves
altering
or
manipulating
expression
can
be
enhanced
by
designed
carry
various
genetic
materials.
Similarly,
improve
efficacy
ERT
lysosomal
storage
(LSDs)
facilitating
delivery
brain,
overcoming
issues
like
immunogenicity
instability.
Taken
together,
explores
potential
revolutionizing
treatment
options
highlighting
their
advantages
future
directions
rapidly
evolving
field.
Keywords:
system,
nanoparticle,
therapy,
Advanced Materials,
Год журнала:
2024,
Номер
36(18)
Опубликована: Янв. 15, 2024
Abstract
Mitochondria,
widely
known
as
the
energy
factories
of
eukaryotic
cells,
have
a
myriad
vital
functions
across
diverse
cellular
processes.
Dysfunctions
within
mitochondria
serve
catalysts
for
various
diseases,
prompting
widespread
demise.
Mounting
research
on
remedying
damaged
indicates
that
constitute
valuable
target
therapeutic
intervention
against
diseases.
But
less
clinical
practice
and
lower
recovery
rate
imply
limitation
traditional
drugs,
which
need
further
breakthrough.
Nanotechnology
has
approached
favorable
regiospecific
biodistribution
high
efficacy
by
capitalizing
excellent
nanomaterials
targeting
drug
delivery.
Mitochondria‐remedying
nanodrugs
achieved
ideal
effects.
This
review
elucidates
significance
in
cells
organs,
while
also
compiling
mortality
data
related
Correspondingly,
nanodrug‐mediate
strategies
applicable
mitochondria‐remedying
disease
are
detailed,
with
full
understanding
roles
dysfunction
advantages
nanodrugs.
In
addition,
future
challenges
directions
discussed.
conclusion,
this
provides
comprehensive
insights
into
design
development
nanodrugs,
aiming
to
help
scientists
who
desire
extend
their
fields
engage
interdisciplinary
subject.
ACS Nano,
Год журнала:
2024,
Номер
18(11), С. 7890 - 7906
Опубликована: Март 6, 2024
Ferroptosis
is
a
vital
driver
of
pathophysiological
consequences
Alzheimer's
disease
(AD).
High-efficiency
pharmacological
inhibition
ferroptosis
requires
comprehensive
coordination
diverse
abnormal
intracellular
events,
which
an
urgent
problem
and
great
challenge
for
its
application
in
AD
treatment.
Herein,
triphenylphosphonium-modified
quercetin-derived
smart
nanomedicine
(TQCN)
developed
multipronged
anti-ferroptosis
therapy
AD.
Taking
advantage
the
favorable
brain-targeting
mitochondria-locating
properties,
TQCN
can
efficiently
chelate
iron
through
phytopolyphenol-mediated
spontaneous
self-assemble
into
metal-phenolic
nanocomplexes
situ,
exerting
escalating
exogenous
offensive
effects
to
attenuate
overload
induced
free
radical
burst.
Meanwhile,
Nrf2
signaling-mediated
endogenous
defensive
system
reconstituted
restore
metabolism
homeostasis
represented
by
export
storage
enhance
cytoprotective
antioxidant
cascades
lipid
peroxidation
detoxification.
Benefiting
from
multifaceted
regulation
pathogenic
processes
triggering
ferroptosis,
treatment
ameliorate
various
neurodegenerative
manifestations
associated
with
brain
deposition
rescue
severe
cognitive
decline
mice.
This
work
displays
promise
situ
self-assembled
phytopolyphenol-coordinated
intelligent
nanotherapeutics
as
advanced
candidates
against
ferroptosis-driven
progression.
Abstract
Mitochondrial
dysfunction
has
been
recognized
as
the
key
pathogenesis
of
most
neurodegenerative
diseases
including
Alzheimer's
disease
(AD).
The
dysregulation
mitochondrial
calcium
ion
(Ca
2+
)
homeostasis
and
permeability
transition
pore
(mPTP),
is
a
critical
upstream
signaling
pathway
that
contributes
to
cascade
in
AD
pathogenesis.
Herein,
“two‐hit
braking”
therapeutic
strategy
synergistically
halt
Ca
overload
mPTP
opening
put
on
brake
proposed.
To
achieve
this
goal,
magnesium
(Mg
),
natural
antagonist,
siRNA
central
regulator
cyclophilin
D
(CypD),
are
co‐encapsulated
into
designed
nano‐brake;
A
matrix
metalloproteinase
9
(MMP9)
activatable
cell‐penetrating
peptide
(MAP)
anchored
surface
nano‐brake
overcome
blood‐brain
barrier
(BBB)
realize
targeted
delivery
cells
brain.
Nano‐brake
treatment
efficiently
halts
cerebrovascular
endothelial
cells,
neurons,
microglia
powerfully
alleviates
neuropathology
rescues
cognitive
deficits.
These
findings
collectively
demonstrate
potential
advanced
design
nanotherapeutics
pathways
provide
powerful
for
modifying
therapy.
Frontiers in Aging Neuroscience,
Год журнала:
2023,
Номер
15
Опубликована: Ноя. 13, 2023
Alzheimer’s
disease
(AD)
is
a
common
neurodegenerative
disorder
characterized
by
the
accumulation
of
amyloid-beta
(Aβ),
hyperphosphorylation
tau,
and
neuroinflammation
in
brain.
The
blood–brain
barrier
(BBB)
limits
solutes
from
circulating
blood
entering
brain,
which
essential
for
neuronal
functioning.
Focusing
on
BBB
function
important
early
detection
AD
in-depth
study
pathogenic
mechanisms.
However,
mechanism
alteration
still
unclear,
hinders
further
research
therapeutics
that
target
to
delay
progression
AD.
exact
timing
vascular
abnormalities
complex
cause-and-effect
relationships
remain
uncertain.
Thus,
it
necessary
summarize
emphasize
this
process.
First,
review,
current
evidence
dysfunction
summarized.
Then,
interrelationships
mechanisms
between
risk
factors
AD,
such
as
Aβ,
neuroinflammation,
apolipoprotein
E
(ApoE)
genotype
aging,
were
analyzed.
Finally,
we
discuss
status
future
directions
therapeutic
strategies
targeting
BBB.
We
hope
these
summaries
or
reviews
will
allow
readers
better
understand
relationship
Journal of Translational Medicine,
Год журнала:
2023,
Номер
21(1)
Опубликована: Июль 11, 2023
Abstract
Background
Alzheimer's
disease
(AD)
is
the
most
common
neurodegenerative
disease.
Mitochondrial
dysfunction
and
immune
responses
are
important
factors
in
pathogenesis
of
AD,
but
their
crosstalk
AD
has
not
been
studied.
In
this
study,
independent
role
interaction
mitochondria-related
genes
cell
infiltration
were
investigated
using
bioinformatics
methods.
Methods
The
datasets
obtained
from
NCBI
Gene
Expression
Omnibus
(GEO),
data
mitochondrial
was
MitoCarta3.0
database.
Subsequently,
differential
expression
(DEGs)
screening
GSEA
functional
enrichment
analysis
performed.
intersection
DEGs
related
used
to
obtain
MitoDEGs.
MitoDEGs
relevant
determined
by
Least
absolute
shrinkage
selection
operator
multiple
support
vector
machine
recursive
feature
elimination,
as
well
protein–protein
interactions
(PPI)
network
random
forest.
28
kinds
cells
analyzed
ssGSEA,
relationship
between
hub
proportion
levels
verified
models
mice,
OPA1
damage
neuronal
apoptosis
investigated.
Results
functions
pathways
significantly
enriched
including
response
activation,
IL1R
pathway,
metabolism,
oxidative
electron
transport
chain-oxphos
system
mitochondria.
Hub
closely
based
on
PPI
network,
forest
two
learning
algorithms.
Five
associated
with
neurological
disorders
identified
biological
function
examination.
found
be
correlated
memory
B
cell,
effector
CD8
T
activated
dendritic
natural
killer
type
17
helper
Neutrophil,
MDSC,
plasmacytoid
cell.
These
can
also
predict
risk
have
good
diagnostic
efficacy.
addition,
mRNA
BDH1,
TRAP1,
OPA1,
DLD
mice
consistent
results
analysis,
SPG7
showed
a
downward
trend.
Meanwhile,
overexpression
alleviated
induced
Aβ1-42.
Conclusions
potential
identified.
Their
microenvironment
may
play
crucial
occurrence
prognosis
which
provides
new
insight
for
studying
exploring
targets.
Redox Biology,
Год журнала:
2023,
Номер
68, С. 102955 - 102955
Опубликована: Ноя. 8, 2023
Oxygen
metabolism
abnormality
plays
a
crucial
role
in
the
pathogenesis
of
Alzheimer's
disease
(AD)
via
several
mechanisms,
including
hypoxia,
oxidative
stress,
and
mitochondrial
dysfunction.
Hypoxia
condition
usually
results
from
living
high-altitude
habitat,
cardiovascular
cerebrovascular
diseases,
chronic
obstructive
sleep
apnea.
Chronic
hypoxia
has
been
identified
as
significant
risk
factor
for
AD,
showing
an
aggravation
various
pathological
components
such
amyloid
β-protein
(Aβ)
metabolism,
tau
phosphorylation,
dysfunction,
neuroinflammation.
It
is
known
that
excessive
hyperoxia
can
both
result
stress
Oxidative
dysfunction
increase
Aβ
proteins
lead
to
redox
imbalance,
thus
forming
vicious
cycle
exacerbating
AD
pathology.
Hyperbaric
oxygen
therapy
(HBOT)
non-invasive
intervention
its
capacity
significantly
enhance
cerebral
oxygenation
levels,
which
attenuate
aggregation,
However,
further
investigation
imperative
determine
optimal
pressure,
duration
exposure,
frequency
HBOT
sessions.
In
this
review,
we
explore
prospects
with
aim
enhancing
our
understanding
underlying
molecular
mechanisms
AD.
Current
research
aimed
at
attenuating
abnormalities
holds
promise
providing
novel
therapeutic
approaches
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
175, С. 116722 - 116722
Опубликована: Май 9, 2024
Ulcerative
colitis
(UC)
is
a
complex
immune-mediated
chronic
inflammatory
bowel
disease.
It
mainly
characterized
by
diffuse
inflammation
of
the
colonic
and
rectal
mucosa
with
barrier
function
impairment.
Identifying
new
biomarkers
for
development
more
effective
UC
therapies
remains
pressing
task
current
research.
Ferroptosis
newly
identified
form
regulated
cell
death
iron-dependent
lipid
peroxidation.
As
research
deepens,
ferroptosis
has
been
demonstrated
to
be
involved
in
pathological
processes
numerous
diseases.
A
growing
body
evidence
suggests
that
pathogenesis
associated
ferroptosis,
regulation
provides
opportunities
treatment.
However,
specific
mechanisms
which
participates
remain
fully
thoroughly
investigated.
Therefore,
this
review,
we
focus
on
advances
mechanism
recent
years
describe
potential
role
UC.
In
addition,
explore
underlying
crosslinked
pathway
between
other
such
as
macrophages,
neutrophils,
autophagy,
endoplasmic
reticulum
stress,
gut
microbiota
Finally,
also
summarize
compounds
may
act
inhibitors
future.
Bioconjugate Chemistry,
Год журнала:
2023,
Номер
34(8), С. 1349 - 1365
Опубликована: Авг. 3, 2023
Matrix
metalloproteinases
(MMPs)
are
a
class
of
endopeptidases
that
dependent
on
zinc
and
facilitate
the
degradation
extracellular
matrix
(ECM)
proteins,
thereby
playing
pivotal
parts
in
human
physiology
pathology.
MMPs
regulate
normal
tissue
cellular
functions,
including
development,
remodeling,
angiogenesis,
bone
formation,
wound
healing.
Several
diseases,
cancer,
inflammation,
cardiovascular
nervous
system
disorders,
have
been
linked
to
dysregulated
expression
specific
MMP
subtypes,
which
can
promote
tumor
progression,
metastasis,
inflammation.
Various
MMP-responsive
drug
delivery
release
systems
developed
by
harnessing
cleavage
activities
overexpression
affected
regions.
Herein,
we
review
structure,
substrates,
physiological
pathological
functions
various
highlight
strategies
for
designing
nanoparticles
improve
targeting
efficiency,
penetration,
protection
therapeutic
payloads.
Abstract
Alzheimer's
disease
(AD)
is
the
most
common
neurodegenerative
disorder
worldwide.
Because
of
complex
pathogenesis
AD
and
unique
location
lesions,
effective
clinical
treatment
strategies
for
this
remain
elusive.
However,
development
nanotechnology
has
allowed
a
new
era
to
emerge.
nanomedicines
are
products
interdisciplinary
research
that
enable
high
precision
targeted
delivery.
Additionally,
they
can
specifically
regulate
various
pathogenic
factors.
This
review
focuses
on
based
pathological
mechanisms
target
lesions.
We
also
discuss
precise
regulatory
effects
(including
nanomaterials
themselves)
proteins,
neuroinflammatory
molecules,
other
summarize
trials
have
examined
drugs,
highlighting
progress
in
their
translation.
Nanotechnology‐based
nascent
field,
complete
cure
distant
at
present;
therefore,
we
elaborate
shortcomings
current
nanomedicines.
Finally,
prospects
guide
future